GlassScriptPhysician profile
Dawn O Hebert
NPI 1043553993
$7,419.30
in general payments reported to CMS, 2019-2025
32 companies · $972 in 2025
The $972 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,398 · 2022: $1,942 · 2023: $1,243 · 2024: $1,864 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,066 · Education: $13.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,065.74 |
| Education | $13.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,432.36 | 2021-2025 | Lokelma, Farxiga |
| Fresenius USA Marketing, INC. | $969.79 | 2021-2025 | Velphoro, Velphoro |
| Vifor Pharma, INC. | $891.23 | 2021-2025 | Veltassa, Korsuva |
| Akebia Therapeutics INC | $769.06 | 2021-2025 | Auryxia, Vafseo |
| Bayer Healthcare Pharmaceuticals INC. | $462.08 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $349.38 | 2021-2025 | Jynarque |
| Calliditas Therapeutics US INC. | $279.72 | 2022-2025 | Tarpeyo |
| Amgen INC. | $254.31 | 2021-2025 | Tavneos, Krystexxa |
| Alexion Pharmaceuticals, INC. | $194.34 | 2021-2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.00 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $182.85 | 2021-2025 | |
| Medtronic, INC. | $170.39 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $152.92 | 2023-2024 | Purified Cortrophin Gel |
| Daiichi Sankyo INC. | $119.15 | 2021-2025 | Injectafer |
| Mallinckrodt Hospital Products INC. | $105.92 | 2021-2025 | Terlivaz, Acthar |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $102.46 | 2022-2025 | Rayaldee |
| Aurinia Pharma U.S., INC. | $101.06 | 2021-2022 | |
| Genzyme Corporation | $97.41 | 2024 | |
| Nxstage Medical, INC. | $75.76 | 2025 | Nxstage System One |
| Travere Therapeutics, INC. | $72.45 | 2022-2024 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $69.71 | 2022-2025 | Jynarque |
| Pharmacosmos Therapeutics INC. | $64.03 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $62.03 | 2022-2024 | Crysvita |
| Horizon Therapeutics Plc | $59.56 | 2021-2023 | Krystexxa |
| Ardelyx, INC. | $37.51 | 2024-2025 | Ibsrela |
| Lilly USA, LLC | $36.25 | 2024 | Jardiance |
| Novo Nordisk INC | $34.12 | 2024 | Ozempic, Rybelsus |
| Veloxis Pharmaceuticals, INC. | $25.35 | 2021 | |
| Idorsia Pharmaceuticals US INC | $19.85 | 2025 | Tryvio |
| Xeris Pharmaceuticals, INC. | $15.59 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.90 | 2021 | |
| Glaxosmithkline, LLC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Hebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.